Retirement Planning Company of New England’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Buy |
553,297
+3,117
| +0.6% | +$27.5K | 2.17% | 5 |
|
|
2025
Q1 | $4.12M | Buy |
550,180
+35,348
| +7% | +$265K | 2.05% | 5 |
|
|
2024
Q4 | $4.29M | Buy |
514,832
+15,327
| +3% | +$128K | 2.08% | 6 |
|
|
2024
Q3 | $3.47M | Buy |
499,505
+41,205
| +9% | +$286K | 1.73% | 9 |
|
|
2024
Q2 | $2.25M | Buy |
458,300
+28,107
| +7% | +$138K | 1.22% | 18 |
|
|
2024
Q1 | $2.5M | Buy |
430,193
+42,766
| +11% | +$248K | 1.37% | 14 |
|
|
2023
Q4 | $2.54M | Buy |
387,427
+40,025
| +12% | +$262K | 1.14% | 20 |
|
|
2023
Q3 | $1.67M | Sell |
347,402
-7,371
| -2% | -$35.5K | 0.93% | 28 |
|
|
2023
Q2 | $1.81M | Buy |
354,773
+27,190
| +8% | +$139K | 1.04% | 20 |
|
|
2023
Q1 | $1.8M | Buy |
327,583
+30,199
| +10% | +$166K | 1.09% | 18 |
|
|
2022
Q4 | $1.36M | Sell |
297,384
-5,436
| -2% | -$25K | 0.89% | 27 |
|
|
2022
Q3 | $1.89M | Buy |
302,820
+14,900
| +5% | +$92.9K | 1.37% | 12 |
|
|
2022
Q2 | $1.28M | Buy |
287,920
+44,029
| +18% | +$196K | 0.88% | 28 |
|
|
2022
Q1 | $1.23M | Buy |
243,891
+32,823
| +16% | +$165K | 0.69% | 36 |
|
|
2021
Q4 | $1.84M | Buy |
+211,068
| New | +$1.84M | 0.89% | 18 |
|